Trill Impact Ventures is the venture capital arm of Trill Impact, a firm dedicated to addressing environmental and health challenges through innovative technologies. Established in 2019, Trill Impact Ventures focuses on early-stage companies that contribute to the United Nations Sustainable Development Goals (SDGs). Their investment strategy emphasizes sectors such as Green Tech, Life Science, and Impact Enablers, aiming to support transformative solutions that promote sustainability and improve global health.

The team comprises professionals with backgrounds in science, finance, operations, and impact & ESG, applying a hands-on approach to value creation. Trill Impact Ventures has raised over €90 million for its inaugural Ventures Fund, with investments in companies like Open Cosmos, May Health, and Cinclus Pharma.